DDR2 belongs to the receptor tyrosine kinase (RTK) family, mounting evidence has proved DDR2 is correlated to the metastasis of HCC [31, 42], and DDR2 inhibitors have been implicated in the treatment of non-small cell lung cancer (NSCLC) [43]. This evidence concerns the gene DDR2 and hepatocellular carcinoma.